NCT03442504
Breast Cancer Type: HR+ & HER2-negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy
Key Eligibility Criteria:
Gender: Female
Age: 18 Years and older (Adult), Senior)
Location of Metastases:
Additional Notes:
Exclusions:
https://ClinicalTrials.gov/show/NCT03442504